Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
CNY 8.87
(2.31%)
CNY 8.87
(2.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 411.32 Million | 244.21 Million | 255.7 Million | 289.05 Million | 345.22 Million | 276.9 Million |
| Cost of Revenue | 221.33 Million | 139.44 Million | 170.83 Million | 144.26 Million | 197.3 Million | 166.3 Million |
| Gross Profit | 189.99 Million | 104.77 Million | 84.87 Million | 144.79 Million | 147.92 Million | 110.59 Million |
| Operating Expenses | 258.4 Million | 217.85 Million | 132.05 Million | 96.89 Million | 99.16 Million | 96.97 Million |
| Selling, General and Administrative Expenses | 129.65 Million | 113.84 Million | 42.33 Million | 41.25 Million | 46.4 Million | 39.58 Million |
| Research and Development Expenses | 63.18 Million | 63.9 Million | 47.67 Million | 26.31 Million | 27.86 Million | 34.28 Million |
| Other Expenses | -18.93 Million | 40.1 Million | 42.05 Million | 29.32 Million | 24.9 Million | -622.01 Thousand |
| Cost and Expenses | 503.41 Million | 357.3 Million | 302.89 Million | 241.16 Million | 296.46 Million | 263.27 Million |
| Operating Income | -98.34 Million | -113.08 Million | -47.18 Million | 49.55 Million | 35.19 Million | 8.22 Million |
| Interest Expense | 11.76 Million | 3.91 Million | 246.08 Thousand | 2.93 Million | 4.94 Million | 1.82 Million |
| Income Tax Expense | -16.01 Million | -18.18 Million | -12.28 Million | 7.41 Million | 4.49 Million | -1.07 Million |
| Earnings before Tax | -98.38 Million | -142.38 Million | -42.27 Million | 47.18 Million | 38.14 Million | 7.53 Million |
| Net Income | -76.06 Million | -124.2 Million | -29.98 Million | 39.77 Million | 33.64 Million | 8.61 Million |
| Earnings Per Share Basic | -0.18 | -0.30 | -0.07 | 0.09 | 0.08 | 0.02 |
| Earnings Per Share Diluted | -0.18 | -0.30 | -0.07 | 0.09 | 0.08 | 0.02 |
| Weighted Average Shares Outstanding | 422.6 Million | 420 Million | 420 Million | 420 Million | 420 Million | 373.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 422.6 Million | 420 Million | 420 Million | 420 Million | 420 Million | 373.87 Million |
| Gross Margin | 0.46 | 0.43 | 0.33 | 0.50 | 0.43 | 0.40 |
| EBIT Margin | -0.10 | -0.27 | -0.02 | 0.24 | 0.20 | 0.14 |
| Profit Margin | -0.18 | -0.51 | -0.12 | 0.14 | 0.10 | 0.03 |
| EBITDA | -39.29 Million | -96.11 Million | -4.94 Million | 74.71 Million | 71 Million | 30.26 Million |
| Earnings Before Tax Margin | -0.24 | -0.46 | -0.18 | 0.17 | 0.10 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 116 Million | 87.13 Million | 91.97 Million | 411.32 Million | 109.8 Million | 62.81 Million |
| Cost of Revenue | 48.24 Million | 45.36 Million | 53.84 Million | 221.33 Million | 62.67 Million | 34.47 Million |
| Gross Profit | 67.76 Million | 41.77 Million | 38.13 Million | 189.99 Million | 47.13 Million | 28.33 Million |
| Operating Expenses | 110.05 Million | 86.57 Million | 63.74 Million | 509.67 Million | 73.07 Million | 56.52 Million |
| Selling, General and Administrative Expenses | 52.86 Million | 52.62 Million | 45.94 Million | - | -16.01 Million | 75.58 Million |
| Research and Development Expenses | 17.51 Million | 28.2 Million | 17.74 Million | - | 21.76 Million | 11.67 Million |
| Other Expenses | -39.67 Million | -5.75 Million | -46.98 Thousand | -509.67 Million | -2788.47 | -13.4 Thousand |
| Cost and Expenses | 158.3 Million | 131.94 Million | 117.58 Million | 509.67 Million | 135.75 Million | 91 Million |
| Operating Income | -42.29 Million | -44.8 Million | -25.6 Million | -98.34 Million | -51.81 Million | -27.41 Million |
| Interest Expense | 3.78 Million | 3.55 Million | 3.89 Million | 11.76 Million | 3.55 Million | 3.43 Million |
| Income Tax Expense | -5.97 Million | -7.52 Million | -3.27 Million | -16.01 Million | -8.2 Million | -4.57 Million |
| Earnings before Tax | -17.97 Million | -41.45 Million | -23.72 Million | -98.38 Million | -51.81 Million | -27.42 Million |
| Net Income | -15.5 Million | -31.82 Million | -13.6 Million | -76.06 Million | -43.61 Million | -22.85 Million |
| Earnings Per Share Basic | -0.04 | -0.08 | -0.03 | - | -0.10 | -0.05 |
| Earnings Per Share Diluted | -0.04 | -0.08 | -0.03 | - | -0.10 | -0.05 |
| Weighted Average Shares Outstanding | 420.78 Million | 420.78 Million | 420.78 Million | 420.78 Million | 420.78 Million | 420.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 420.78 Million | 420.78 Million | 420.78 Million | 420.78 Million | 420.78 Million | 420.78 Million |
| Gross Margin | 0.58 | 0.48 | 0.41 | 0.46 | 0.43 | 0.45 |
| EBIT Margin | -0.12 | -0.37 | -0.16 | - | -0.25 | -0.38 |
| Profit Margin | -0.13 | -0.37 | -0.15 | -0.18 | -0.40 | -0.36 |
| EBITDA | -14.18 Million | -32.14 Million | -14.52 Million | - | -27.51 Million | -24.05 Million |
| Earnings Before Tax Margin | -0.36 | -0.51 | -0.28 | -0.24 | -0.47 | -0.44 |
CONART
GAU
SU
SGY
TROY
002347